🇺🇸 FDA
Patent

US 11491187

Methods of conditioning patients for T cell therapy

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 11491187 (Methods of conditioning patients for T cell therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K31/664